Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000202596

Medchemexpress LLC Dbco-PEG4-Val-Cit-PAB-MMAE | 2129164-91-4 | 99.2% | 1658.03 g/mol | C88H128N12O19 | 5 MG
SDP

Catalog No. 5000202596
Encompass_Preferred

DBCO-PEG4-Val-Cit-PAB-MMAE is a cleavable drug-linker conjugate that combines a DBCO-functionalized PEG4-Val-Cit-PAB linker with the cytotoxic payload MMAE. It is supplied as a white to off-white solid for use as a click-chemistry reagent and building block in antibody-drug conjugate synthesis; solutions are unstable and should be prepared fresh.

  • Suitable for strain-promoted alkyne-azide cycloaddition (SPAAC)
  • Val-Cit-PAB motif provides a cathepsin-cleavable linker
  • MMAE payload acts as a tubulin polymerization inhibitor
  • High purity supplied (99.18%)
  • Provided as a solid; store powder at -20°C

Catalog No. 50-002-02596 Supplier Medchemexpress LLC Supplier No. HY1363145MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

DBCO-PEG4-Val-Cit-PAB-MMAE is a cleavable drug-linker conjugate that combines a DBCO-functionalized PEG4-Val-Cit-PAB linker with the cytotoxic payload MMAE. It is supplied as a white to off-white solid for use as a click-chemistry reagent and building block in antibody-drug conjugate synthesis; solutions are unstable and should be prepared fresh.

  • Suitable for strain-promoted alkyne-azide cycloaddition (SPAAC)
  • Val-Cit-PAB motif provides a cathepsin-cleavable linker
  • MMAE payload acts as a tubulin polymerization inhibitor
  • High purity supplied (99.18%)
  • Provided as a solid; store powder at -20°C

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.